Skip to main content

Table 5 Clinical performance of sTREM-1 combined with either SAPS II or SOFA score values in predicting all cause ICU mortality

From: Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis

 

AUROCC [95 % CI]

Se (%) [95 % CI]

Sp (%) [95 % CI]

PPV (%) [95 % CI]

NPV (%) [95 % CI]

Positive LR [95 % CI]

Negative LR [95 % CI]

sTREM-1 (>954.4 ng/L) & SAPS II (>67.5)

0.68 [0.59–0.78]

38.8 % [25.2–53.8]

98.6 % [95.0–99.8]

91.3 % [58.8–100]

80.3 % [79.3–83.3]

27.30 [5.08–261.50]

0.63 [0.48–0.78]

sTREM-1 (>954.4 ng/L) & SOFA D1 (>7.5)

0.70 [0.61–0.80]

55.1 % [40.2–69.3]

85.8 % [78.9–91.1]

57.4 % [41.9–72.2]

84.6 % [77.8–89.8]

3.88 [3.20–29.70]

0.57 [0.41–0.76]

  1. AUROCC area under receiver operating characteristics curve, Se sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, LR likelihood ratio, sTREM-1 soluble triggering receptor expressed on myeloid cells-1, SAPS simplified acute physiologic score, SOFA sequential organ failure assessment, ICU intensive care unit